The dark side of pulmonary alveolar proteinosis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pulmonary alveolar proteinosis (PAP) can unpredictably progress to pulmonary fibrosis. Early recognition and genetic analysis are crucial for managing this rare but serious complication, potentially guiding lung transplant decisions.
Area Of Science
- Pulmonology
- Rare Diseases
- Fibrotic Lung Diseases
Background
- Pulmonary alveolar proteinosis (PAP) presents an unpredictable clinical course.
- While often benign, PAP is associated with pulmonary fibrosis, posing therapeutic and prognostic challenges.
Purpose Of The Study
- To highlight the rare complication of pleuro-parenchymal fibroelastosis (PPFE) in autoimmune PAP.
- To emphasize the need for vigilant monitoring and potential genetic analysis in PAP patients.
Main Methods
- Case report of an autoimmune PAP patient who developed PPFE after 6 years.
- Patient underwent bilateral lung transplantation for end-stage respiratory failure.
Main Results
- The patient developed PPFE, a severe fibrotic lung disease, 6 years after autoimmune PAP diagnosis.
- End-stage respiratory failure necessitated bilateral lung transplantation.
Conclusions
- Pulmonary fibrosis development in PAP is underreported, with unknown predictors.
- Strict follow-up is essential to detect fibrotic evolution early.
- Genetic analysis may identify patients susceptible to fibrotic progression.
- Early referral to lung transplant centers is vital for patients with progressive disease.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
The pathophysiology of pneumonia involves the following steps:
• Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract.
• Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly...
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...